research use only
Cat.No.S4204
|
In vitro |
DMSO
: 29 mg/mL
(198.43 mM)
Water : 29 mg/mL Ethanol : 29 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 146.14 | Formula | C6H10O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 652-67-5 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | D-Isosorbide,Dianhydro-D-glucitol | Smiles | C1C(C2C(O1)C(CO2)O)O | ||
| In vitro |
Isosorbide increases urine volume by increasing the amount of osmotically active solute in the urine. This compound also increases the osmolarity of plasma. It is used to prevent or treat chest pain (angina). It works by relaxing the blood vessels to the heart, so the blood and oxygen supply to the heart is increased. |
References |
|---|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05954689 | Not yet recruiting | Tourniquets|Anesthesia Conduction|Anesthetics Local|Hypertension |
Hospital da Luz Portugal |
July 10 2023 | Not Applicable |
| NCT05341856 | Unknown status | Recurrent Pregnancy Loss |
Al-Azhar University |
May 1 2022 | Early Phase 1 |
| NCT04297241 | Completed | Fontan |
Children''s Hospital Medical Center Cincinnati |
December 12 2019 | Phase 2 |
| NCT02053493 | Completed | Heart Failure |
Adrian Hernandez|National Heart Lung and Blood Institute (NHLBI)|Mayo Clinic|University of Vermont|Duke University |
April 2014 | Phase 2 |
| NCT02712125 | Completed | Isolated (Idiopathic) Oligohydramnios |
Benha University |
August 2013 | Phase 2|Phase 3 |
| NCT00930618 | Completed | Prolonged Pregnancy|Nulliparity |
Assistance Publique - Hôpitaux de Paris |
June 2009 | Phase 3 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.